Title : Pediatric phase I trial design using maximum target inhibition as the primary endpoint - Meany_2010_J.Natl.Cancer.Inst_102_909 |
Author(s) : Meany H , Balis FM , Aikin A , Whitcomb P , Murphy RF , Steinberg SM , Widemann BC , Fox E |
Ref : J Natl Cancer Inst , 102 :909 , 2010 |
Abstract : |
PubMedSearch : Meany_2010_J.Natl.Cancer.Inst_102_909 |
PubMedID: 20460632 |